Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Oral spironolactone may be effective for female pattern hair loss with a low rate of side effects.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Higher doses of isotretinoin may lead to more hair loss.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Chinese medicine may help hair growth and reduce hair loss in androgenetic alopecia.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Nail loss may be a side effect of the MS drug teriflunomide.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.